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PURPOSE. We determined the glaucoma screening performance of regional optical coherence
tomography (OCT) layer thickness measurements in the peripapillary and macular region, in a
population-based setting.
METHODS. Subjects (n ¼ 1224) in the Rotterdam Study underwent visual field testing
(Humphrey Field Analyzer) and OCT of the macula and optic nerve head (Topcon 3-D OCT-
1000). We determined the mean thicknesses of the retinal nerve fiber layer (RNFL), retinal
ganglion cell layer (RGCL), and inner plexiform layer for regions-of-interest; thus, defining a
series of OCT parameters, using the Iowa Reference Algorithms. Reference standard was the
presence of glaucomatous visual field loss (GVFL); controls were subjects without GVFL, an
intraocular pressure (IOP) of 21 mm Hg or less, and no positive family history for glaucoma.
We calculated the area under the receiver operating characteristics curve (AUCs) and the
sensitivity at 97.5% specificity for each parameter.
RESULTS. After excluding 23 subjects with an IOP > 21 mm Hg and 73 subjects with a positive
family history for glaucoma, there were 1087 controls and 41 glaucoma cases. Mean RGCL
thickness in the inferior half of the macular region showed the highest AUC (0.85; 95%
confidence interval [CI] 0.77–0.92) and sensitivity (53.7%; 95% CI, 38.7–68.0%). The mean
thickness of the peripapillary RNFL had an AUC of 0.77 (95% CI, 0.69–0.85) and a sensitivity
of 24.4% (95% CI, 13.7–39.5%).
CONCLUSIONS. Macular RGCL loss is at least as common as peripapillary RNFL abnormalities in
population-based glaucoma cases. Screening for glaucoma using OCT-derived regional
thickness identifies approximately half of those cases of glaucoma as diagnosed by perimetry.
Keywords: OCT, retinal thickness measurement, Iowa Reference Algorithms, population-
based evaluation
Glaucoma is a chronic optic neuropathy with associateddamage of retinal ganglion cells, which results in visual
field loss. This damage is characterized by increased cupping of
the optic nerve head (ONH), and thinning of the retinal nerve
fiber layer (RNFL) and retinal ganglion cell layer (RGCL), as has
been shown with fundus photography, histology, and optical
coherence tomography (OCT).1–3 These structures can be
assessed with the Heidelberg Retina Tomograph (HRT; Heidel-
berg Engineering, Dossenheim, Germany)4 or with scanning
laser polarimetry (GDx Nerve Fiber Analyzer; Carl Zeiss
Meditec, Jena, Germany).5,6 These techniques showed an
apparently favorable screening performance in some specific
study populations.7,8 In population-based settings, however,
the screening performance of these techniques was rather
poor.9–12 A good screening performance in population-based
settings is indispensable for an effective case finding for
population-based glaucoma research.
The OCT is a newer technique, which can quantify volumes
of different retinal layers through segmentation and detect
glaucomatous changes of retina and ONH.3,13 Similar to what
was found in HRT and GDx, many studies reported a favorable
screening performance of OCT in clinical settings. Thus far,
only two studies were designed as population-based studies,
with relatively small sample sizes and, as a consequence, a very
small number of cases (9 cases14 and 6 cases,15 respectively).
Population-based studies are attractive, compared to clinical
studies, because of the absence of selection bias.
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The aim of this study was to determine, in a population-
based setting, the glaucoma screening performance of OCT
combined with fully 3D analysis, with glaucomatous visual
field loss (GVFL) as the reference standard. Specifically, we
evaluated the following metrics: peripapillary RNFL thickness,
macular mean RGCL, RNFL, and inner plexiform layer (IPL)
thicknesses, and mean RGCL, RNFL, and IPL thicknesses in
regions based on the trajectories of the nerve fiber bundles and
the macular vulnerability zone.16–20
METHODS
Study Population
The Rotterdam Study is a prospective cohort study investigat-
ing age-related disorders.21 It is conducted in Rotterdam, The
Netherlands. It started in 1990 with the original cohort, which
comprised 7983 subjects aged 55 years or older. The study was
enlarged with two additional cohorts in 2000 (3011 subjects
aged 55 years or older) and 2006 (3932 subjects aged 45 years
or older). Follow-up examinations still are ongoing. The
ophthalmic examinations have been described previously.22
All measurements were conducted after the Medical Ethics
Committee of the Erasmus Medical Center had approved the
study protocol and after all subjects had provided written
informed consent in accordance with the tenets of the
Declaration of Helsinki.
Cases and Controls
We included 1224 consecutive subjects from the third
Rotterdam Study cohort (baseline examinations) and the
original Rotterdam Study cohort (fourth follow-up examina-
tions) who had undergone intraocular pressure (IOP) mea-
surement, perimetry, and spectral domain OCT (see below).
After this consecutive inclusion, we continued to include
subjects with GVFL to circumvent the low prevalence of
glaucoma. Subjects with GVFL (see below) in at least one eye
were considered cases, irrespective of their IOP. Subjects
without GVFL, an IOP of 21 mm Hg or less, and no positive
family history for glaucoma were considered controls. If both
eyes were eligible, we used data from a random eye. If GVFL
was present in one eye, we used data from the eye with GVFL.
Due to the extended inclusion of cases, which took place in a
younger cohort, the cases and controls were incidentally
almost perfectly age-matched (see Results section), even
though a difference in age would have been expected.23
Visual Field Testing
All subjects in the present study were tested for visual field
defects using the Humphrey Field Analyzer (HFA; Carl Zeiss
Meditec, Jena, Germany). Details of this assessment have been
published previously.23 Briefly, each eye was screened using a
52-point supra-threshold test that covered the central visual
field with a radius of 248. If the subject did not respond to the
light stimulus (6 dB above a threshold-related estimate of the
hill of vision) in at least three contiguous test points (or four
including the blind spot) in two supra-threshold tests, full-
threshold HFA testing with a 24-2 grid was performed. The full-
threshold tests were classified as abnormal if at least one of
three criteria was met: (1) a Glaucoma Hemifield Test ‘‘outside
normal limits,’’ (2) a minimum of three contiguous points in
the pattern deviation probability plot with a sensitivity
decreased to P < 0.05 of which at least one point to P <
0.01, or (3) a Pattern Standard Deviation P < 5%. Visual field
loss was considered to be present if it was reproducible, that is,
the abnormalities had to be present on the full-threshold test
and on both supra-threshold tests. Defects had to be in the
same hemifield and at least one depressed test point had to
have exactly the same location on all fields. Fundus photo-
graphs, ophthalmic examination reports, medical histories, and
MRI scans of the brain were checked for disorders that could
explain the visual field loss. If no other cause could be
identified, and no homonymous defects and artifacts like rim
artifacts were found, the visual field loss was considered GVFL.
Discrepancies were resolved by consensus.
Optic Disc Assessment
Subjects underwent optic disc assessment using the HRT
device. The cutoff values for glaucomatous optic neuropathy
(GON) were based on the linear cup-disc ratio (LCDR) and
defined as follows: 0.67 for small discs (up to 1.5 mm2), 0.71
for discs 1.5 to 2.0 mm2, and 0.76 for large discs (>2.0 mm2).10
We excluded HRT scans that exceeded a SD of 50 lm.
Optical Coherence Tomography (OCT)
Since 2007, the macula and ONH of all visiting subjects have
been imaged with OCT (Topcon 3-D OCT-1000; Topcon,
Tokyo, Japan). At the beginning of the study, only the right eye
was scanned in the interest of time. We included n ¼ 883
subjects during this period. In a later stage, both eyes were
scanned. Due to an update during the study, seven glaucoma
cases were scanned with the Topcon OCT-2000 instead of the
OCT-1000 (the inclusion of cases was extended because of the
low prevalence of GVFL, see above). Importantly, the
segmentation algorithm corrects for differences between these
two devices. To confirm this, we excluded these seven cases
and reanalyzed the data (see Results section). Macular and
ONH scans were centered around the fovea and the center of
the ONH, respectively. Figure 1 shows the scanned areas. The
scans were performed in the horizontal direction. Volume size
was 63 63 1.68 mm (5123 1283 480 voxels). Volumes with
severe motion artifacts caused by head or eye movements and
macular volumes in which more than 20% of the volume was
unsegmentable were excluded. The ONH volumes with one or
more clock hour segments (see below) in which the RNFL was
completely unsegmentable also were excluded. All included
OCT volumes were segmented into 10 layers (11 surfaces),
using the Iowa Reference Algorithms (available in the public
domain from http://biomed-imaging.uiowa.edu/downloads), a
fully three-dimensional automated segmentation algo-
rithm.24–26 We studied the RNFL (between surfaces 1 and 2),
FIGURE 1. Schematic overview of the area of the macular scan (left
square) and ONH scan (right square).
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the RGCL (between surfaces 2 and 3), and the IPL (between
surfaces 3 and 4). For the macula, we calculated the
thicknesses of these layers in 100 square blocks of 0.6 3 0.6
mm each. For the ONH, we calculated the thickness of the
RNFL in between two circles with radii of 1.03 and 1.84 mm
centered on the manually determined ONH center.27 This was
done in 12 peripapillary segments of 308 each (one clock
hour).
Data Analysis
We calculated the area under the receiver operating charac-
teristics Curves (AUC) for different parameters. Starting with
the 100 blocks from the macular region and the 12
peripapillary segments, we constructed a series of parameters.
These parameters comprised global measures and more
detailed measures, based on the pathophysiology of glaucoma.
We used the retinal nerve fiber bundle trajectories as described
by Jansonius et al.18,19 to divide the macular area in 11
subregions. As this subdivision might be too fine-grained given
the test–retest variability of OCT measurements,27 we divided
the macular area in 4 larger scale subregions as well. We
focused on a specific region of the macula, the macular
vulnerability zone (MVZ)17 and—related to the MVZ—the
inferior half of the macular scan. Table 1 lists all included
parameters; Figure 2 presents the 11 and 4 subregions based
on the trajectories, and the MVZ.
For AUC analysis, a single variable is needed. For the global
measures, there is only one region-of-interest and, thus, the
average thickness of a particular layer in that region is a single
variable. For the measures based on a number of subregions,
we made a single variable (a score) by counting the number of
subregions that had a thickness of a particular layer below a
certain percentile. This was repeated for a series of percentiles
(P0.5, P1, P2, P5, P10, P20; based on the controls). The
percentile yielding the highest AUC was selected. Analyses
concerning the macular region were done for the RGCL, and
unweighted summations of RGCLþRNFL, and RGCLþRNFLþ
IPL. Analyses concerning the ONH region were based on the
RNFL. The 95% percent confidence intervals (95% CI) were
calculated and the highest AUCs from the macula and ONH
were compared using a technique described by DeLong et al.28
We performed a cross-validation by calculating an adjusted
AUC of the parameter with the highest (uncorrected) AUC and
sensitivity using a leave-one-out resampling method.
We calculated the sensitivity at a fixed high specificity of
97.5% for all included parameters, for the best percentile/layer
combination, if applicable.29 Sensitivities were compared with
a McNemar test. For the parameter with the highest AUC and
highest sensitivity, the positive and negative predictive values
were calculated. For these parameters, we also calculated the
sensitivity and AUC for glaucoma defined as HRT-based GON
(see above) and as the presence of GON and GVFL. Analyses
were performed with IBM SPSS Statistics Release 21.0.0.1 (IBM
Corp., Armonk, NY, USA). The comparisons of AUCs were
performed using MedCalc Statistical Software version 12.7.7
(MedCalc Software bvba, Ostend, Belgium; available in the
public domain at http://www.medcalc.org; 2013). The leave-
one-out cross-validation was performed using R version 3.0.2
(cvAUC package; R Foundation for Statistical Computing,
Vienna, Austria; available in the public domain at http://
www.R-project.org/; 2013). A P value below 0.05 was
considered statistically significant.
RESULTS
We excluded 23 controls with an IOP > 21 mm Hg and 73
controls with a positive family history for glaucoma. After this,
there were 1128 subjects left: 1087 controls and 41 GVFL
cases. Controls and cases did not differ in age (74.8 vs. 74.2
years, P ¼ 0.66) or sex (40.6 vs. 41.5% male, P ¼ 0.91). The
average (median) mean deviation (MD) of the visual field of the
cases was7.5 (6.5) dB (SD,4.9 dB; interquartile range,3.8
to10.5 dB).
TABLE 1. Overview of the Included OCT Parameters
Region Parameter Layer Measure*
ONH Mean thickness (lm) in peripapillary region RNFL Continuous
Number of abnormally thin subregions; subregions are peripapillary
308 segments with the 4 nasal segments combined
RNFL Score 0–9
Macula Mean thickness (lm) in scan region RGCL Continuous
RGCL þ RNFL
RGCL þ RNFL þ IPL




RGCL þ RNFL þ IPL




RGCL þ RNFL þ IPL
Mean thickness in MVZ (lm, Fig. 2C) RGCL Continuous
RGCL þ RNFL
RGCL þ RNFL þ IPL
Mean thickness in inferior half of macular scan (lm) RGCL Continuous
RGCL þ RNFL
RGCL þ RNFL þ IPL
Combined 11 macular subregions (Fig. 2A) with weight factor 4/11 combined
with 5 ONH subregions: 2 superior 308 segments, 2 inferior 308
segments, and 1 nasal 1208 segment
Score 0–9
4 macular subregions (Fig. 2B) combined with 5 ONH subregions: 2
superior 308 segments, 2 inferior 308 segments, and 1 nasal 1208
segment
Score 0–9
* Continuous variable or number of subregions with a thickness below a certain percentile.
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Table 2 shows the AUCs for the different OCT parameters.
None of the parameters had a higher AUC than the mean RGCL
thickness in the entire macular region (0.85; 95% CI, 0.78–
0.93). A more detailed analysis did not improve the AUC (0.85
for 11 bundles), nor did confining the analysis to the inferior
half of the macular region (0.85). Including additional retinal
layers to the thickness measurements (RGCLþ RNFL or RGCL
þ RNFL þ IPL), acceptable from an anatomical perspective,
yielded lower AUC point estimates. The average RNFL
thickness in the ONH volume yielded an AUC of 0.77 (95%
CI, 0.69–0.85; significantly lower than that of the mean RGCL
thickness in the entire macular region; P ¼ 0.01); a detailed
analysis of 9 peripapillary segments resulted in essentially the
same AUC (0.78). Combined analysis of macular bundles and
peripapillary segments did not yield any diagnostic improve-
ment.
Table 3 shows the sensitivity at an approximately 97.5%
specificity level for the layer and/or percentile with the highest
AUC for each OCT parameter. The mean RGCL thickness in the
inferior half of the macular region had the highest sensitivity
(53.7%; 95% CI, 38.7–68.0%) followed by the mean RGCL
thickness in the MVZ (46.3%; 95% CI, 32.1–61.3%). The
positive and negative predictive values of the former parameter
were 44.9% and 98.2%, respectively. The difference between
these two sensitivities was not significant (P¼ 0.25). The mean
peripapillary RNFL thickness had a sensitivity of 24.4% (95%
CI, 13.7–39.5%; P < 0.001 compared to the mean RGCL
thickness in inferior half of the macular region). The corrected
FIGURE 2. Division of macular scan region in 11 (A) and 4 (B) color-coded subregions, based on the nerve fiber bundle trajectories as described by
Jansonius et al.,18,19 and the MVZ (C) as described by Hood et al.17 Dark line represents the border between the superior and inferior part of the
scan. Division of peripapillary region in 9 color-coded segments ([D]; *denotes segments that are replaced by macular subregions in the combined
variables as described in Table 1).
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AUC for the parameter with the highest AUC and sensitivity
(mean RGCL thickness in the inferior half of the macular
region; AUC ¼ 0.85) was 0.84 (leave-one-out cross-validation).
No significant differences were found for this parameter after
exclusion of the subjects who were scanned with the OCT-
2000: AUC and sensitivity at 97.5% specificity were 0.83 and
52.9%, respectively.
Of the 41 cases, 19 were not identified by ‘‘mean RGCL
thickness in the inferior half of the macular region.’’ Figure 3
shows the MD and pattern standard deviation (PSD) values of
the 41 cases, stratified according to true-positive and false-
negative status. The MD and PSD values of the 19 false-
negatives seemed to be higher and lower, respectively, than
that of the 22 true-positives, but the differences were not
significant (MD,6.2 vs.8.6 dB, P¼ 0.13; PSD, 7.1 vs. 9.0 dB,
P¼0.09). Figure 4 presents the mean sensitivity in the superior
half of the visual field (8 superiorly located central test
locations of 24-2 grid) as a function of the mean RGCL
thickness in the inferior half of the macular scan, for the 41
cases with GVFL. There was a significant association (R¼ 0.35,
P ¼ 0.026). True-positives had on average a lower threshold
sensitivity in the central part of the superior visual field
compared to false-negatives (19.6 vs. 24.7 dB, P ¼ 0.042).
There was no difference in axial length between cases and
controls (23.8 vs. 23.5 mm, P ¼ 0.09; based on 33 cases and
903 controls for which axial length data were available), but
true-positives had a greater axial length than false-negatives
(24.1 vs. 23.4 mm, P ¼ 0.049). Finally, Figure 5 presents the
mean superior macular thickness versus the mean inferior
macular thickness for the RGCL, for cases and controls.
Table 4 shows the sensitivity at 97.5% specificity and AUC
for patients with HRT-based GON (n¼37), and GON and GVFL
(n¼10). The sensitivity and AUC of the ‘‘mean RGCL thickness
in the inferior half of the macular region’’ increased from 53.7%
to 70.0% and from 0.85 to 0.93, respectively, for cases with
GON and GVFL.
TABLE 2. AUCs for the OCT Parameters as Listed in Table 1
Region Parameters Layer
AUC
P0.5 P1 P2 P5 P10 P20
ONH Mean of all segments RNFL 0.77
Score based on 9 segments RNFL 0.57 0.64 0.66 0.76 0.78 0.76
Macula Mean in whole scan RGCL 0.85
RNFL þ RGCL 0.83
RNFL þ RGCL þ IPL 0.78
Score based on 11 bundles RGCL 0.68 0.80 0.82 0.85 0.83 0.84
RNFL þ RGCL 0.67 0.76 0.82 0.84 0.84 0.82
RNFL þ RGCL þ IPL 0.64 0.71 0.77 0.81 0.81 0.78
Score based on 4 bundles RGCL 0.60 0.71 0.78 0.83 0.83 0.84
RNFL þ RGCL 0.65 0.68 0.78 0.80 0.82 0.81
RNFL þ RGCL þ IPL 0.57 0.65 0.73 0.79 0.79 0.76
Mean in MVZ RGCL 0.83
RNFL þ RGCL 0.79
RNFL þ RGCL þ IPL 0.78
Mean in inferior scan RGCL 0.85
RNFL þ RGCL 0.81
RNFL þ RGCL þ IPL 0.79
Combined Score based on ONH RNFL (P10)
þ 11 macular bundles RGCL (P5)
0.85
Score based on ONH RNFL (P10) þ
4 macular bundles RGCL (P20)
0.85
P0.5, P1, P2, P5, P10, and P20 are percentiles based on the controls in this study population that are used as cutoff values to calculated the
scores (see Table 1).
TABLE 3. Sensitivity, at 97.5% Specificity, for the Layers and Percentiles With the Best AUC (Table 2)
Region Variable % Specificity* % Sensitivity
ONH Mean RNFL of all segments 97.5 24.4
RNFL score: P10 96.1 29.3
98.0 14.6
Macula Mean of whole scan, RGCL 97.5 36.6
11 bundles, RGCL P5 97.2 29.3
98.1 29.3
4 bundles, RGCL P20 93.8† 41.5
Mean of MVZ, RGCL 97.5 46.3
Mean of inferior scan, RGCL 97.5 53.7
Combined ONH RNFL P10 þ 4 bundles RGCL P20 97.0 31.7
98.1 22.0
ONH RNFL P10 þ 11 bundles RGCL P5 97.5 26.8
* If none of the cutoff points yielded a specificity of exactly 97.5%, two specificity values were reported that enclose 97.5%.
† Highest possible specificity for this parameter.
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DISCUSSION
Our results showed that the mean RGCL thickness in the
inferior half of the macular region has the best performance in
terms of AUC and sensitivity at 97.5% specificity in this
population-based OCT study. The sensitivity of 53.7% results in
missing almost half of GFVL cases if OCT is applied for mass
screening for glaucoma, as defined by our criteria of visual field
loss.
The AUC is a commonly reported measure for the
diagnostic performance of a test. It is a summary measure
compiled from the sensitivity and specificity for a range of cut-
off values. Given the low prevalence of glaucoma in a
population, however, sensitivities at low specificities have
diminished relevance. This makes sensitivity at a fixed high
specificity a more relevant measure. Therefore, we consider
‘‘mean RGCL thickness in the inferior half of the macular
region’’ the best parameter, despite the fact that many other
parameters had comparable AUCs. The 97.5% specificity level
has an optimal balance between false-positive and true-positive
classification for risk factor analysis.29 For screening as part of
preventing a disease, the specificity also is a trade-off between
yield and cost, and a different cutoff value may be preferred
from either perspective. However, a cost-effectiveness analysis
is not the purpose of this current study.
Recently, several studies focusing on glaucomatous macular
damage have been published.30–37 The macular ganglion cell
complex (GCC; i.e., RNFLþ RGCLþ IPL) is on average thinner
in glaucomatous eyes and correlates with visual field changes.
Our study included mainly patients with early and moderate
FIGURE 3. Scatterplot of mean deviation versus pattern SD for the 41
cases with GVFL. Green dots represent the cases (n ¼ 22) correctly
classified by the mean RGCL thickness in the inferior half of the
macular region (true-positives). Blue dots represent the false-negative
cases (n¼ 19).
FIGURE 4. Scatterplot of the mean RGCL thickness in the inferior half
of the macular scan versus the mean sensitivity of the eight superiorly
located central test locations of the 24-2 grid for the 41 cases with
GVFL.
FIGURE 5. Mean superior macular thickness versus mean inferior
macular thickness for the RGCL, for cases (green) and controls (blue).
TABLE 4. Sensitivity at 97.5% Specificity and AUC for Mean RGCL
Thickness in the Inferior Half of the Macular Region and Mean RNFL
Thickness in Peripapillary Region, for Cases With HRT-Based GON (n¼




Mean of macular inferior scan, RGCL
Sensitivity 53.7 24.3 70.0
AUC 0.85 0.71 0.93
Mean RNFL of all peripapillary segments
Sensitivity 24.4 16.2 40.0
AUC 0.77 0.78 0.95
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glaucoma (median MD was 6.5 dB) and in this group the
macular region was affected in approximately half of the
patients (Table 3; sensitivity for the mean RGCL thickness in
the inferior half of the macular region 53.7%). This is in
agreement with recent studies assessing the macula with
perimetry in detail and underlines the importance of macula
testing in glaucoma care,38,39 something that has been
abandoned with the adoption of 6 3 6 degree perimetric
grids. Hood et al.17 suggested that the RGCL in a specific part
of the inferior macula associates with the region of the optic
disc where most glaucomatous damage occurs; the macular
vulnerability zone. In our study, we found a sensitivity of 46.3%
for this macular area. Because thickness measurements for this
specific area are not available for each OCT device, we
calculated the AUC and sensitivity for ‘‘mean RGCL thickness
in the inferior half of the macular region’’ and found a
sensitivity that was at least as high as the sensitivity of the MVZ
(53.7%; P ¼ 0.25 compared to the sensitivity of 46.3% of the
MVZ). Taking the pathophysiology of glaucoma into account
by using the 4 and 11 bundle regions-of-interest approach did
not improve performance. Presumably, the large intersubject
variability in the retinal nerve fiber bundle trajectories might
explain the poor performance of an approach based on the
average trajectories.19 We previously found that combined
analysis of the RNFL and RGCL thicknesses allowed for
analyzing smaller regions-of-interest.27 This approach did not
increase performance in the current analysis, probably because
smaller regions-of-interest were less informative for other
reasons, like the intersubject variability of the retinal anatomy
mentioned above. Glaucomatous damage causes retinal glio-
sis,40 which may mask RNFL thinning on OCT.41
Table 5 gives an overview of published literature regarding
glaucoma screening with OCT. We included studies with
information on AUC, and/or sensitivity and specificity and with
more than 200 cases and healthy controls in total. Four
nonpopulation-based studies investigated macular parameters,
in various layers, being the GCC,42 RNFLþRGCLþ IPL,43 RGCL
þ IPL,44 and the RNFL.45 These macular parameters had AUCs
ranging from 0.87 to 0.96; the peripapillary RNFL and ONH
parameters in these studies had AUCs varying from 0.78 to
0.99. Obviously, a comparison of these studies is hampered by
heterogeneity of the applied glaucoma definitions (reference
standards): three of four studies used a glaucoma definition
based on visual field loss and GON. In contrast, our reference
standard for calling a case glaucoma was based solely on visual
field loss (GVFL), that is, on functional changes. This may have
biased the results toward a lower agreement with OCT, a
technique that measures structural changes. With a more strict
glaucoma definition based on GON and GVFL, the sensitivity
for mean RGCL thickness in the inferior half of the macular
region increased from 53.7% to 70.0%, with an increase in AUC
from 0.85 to 0.93 (Table 4), and again the macular region
outperformed the peripapillary region (Table 4). Generally, the
reported AUCs of other studies seem to surpass that of our
study. However, our study is a population-based study and
cannot be compared to clinical studies, with their selection
bias, directly. In a clinical setting, perimetry is generally
confined to those patients who have a suspected ONH
appearance. This will induce a selection bias toward abnormal
structure, favoring an imaging technique, like OCT. In our
population-based setting, perimetry was performed in all
subjects. Baskaran et al.46 included 508 healthy controls from
a population-based study, but they selected 184 glaucoma cases
from an eye center, where glaucoma diagnosis was based on
GON and corresponding visual field loss. Li et al.15 included
community-based volunteer subjects, including 204 healthy
controls and six cases with definite glaucoma, which also was
defined as visual field loss and GON. Their best parameter was
the cup diameter (AUC, 0.91; 83% sensitivity at 84%
specificity). Another study invited individuals randomly from
two rural areas14 and consisted of 129 healthy controls and
only nine glaucoma cases. The inclusion criterion for being a
case was glaucomatous changes of the optic disc. Their best
AUC (0.99) was found for the parameter ‘‘‡1 peripapillary
quadrant sectors below P1’’; with 100% sensitivity at 96%
specificity.
Although the sensitivity we found is lower than in these
clinical case-control studies, it is relatively high compared to
other imaging techniques used in population-based studies. In
the Rotterdam Study, we found a sensitivity of 35% at 97.5%
specificity for the best parameter of the HRT (linear cup-disc
ratio adjusted for disc area)10; a similar modest HRT screening
performance was found in the Tajimi and Blue Mountains Eye
studies.9,11 Another study investigated scanning laser polarim-
etry (GDx-VCC) and found a sensitivity of 25.6% at a specificity
of 97.0% for the parameter with the highest AUC (0.89; nerve
fiber indicator).12
The strength of this study is the large number of subjects.
However, the number of cases is a limitation, a consequence of
the population-based design. There were 41 cases, which is
lower than most clinical studies in Table 5. At the beginning of
our study, we scanned only the right eye and, therefore, we
missed 15 cases with unilateral GVFL in the left eye. Another
strength is the glaucoma reference standard, which is based on
visual field loss only. This avoids a selection bias toward
abnormal structure (see above). On the other hand, we have
probably missed some glaucoma cases with small macular
defects and cases with superficial defects, due to the course 6
3 6 degree grid in combination with the requirement of three
contiguous abnormal test locations and the preselection with
supra-threshold testing, respectively.
Analyzing a series of parameters bears the risk of chance
findings. We tried to avoid this as much as possible by limiting
the number of parameters and by focusing on parameters
inspired by the anatomy and pathophysiology of glaucoma. In
the ideal situation, an external validation is performed. Data for
such a validation were not available. For that reason, we
performed a cross-validation using a leave-one-out resampling.
The resulting adjusted AUC (0.84) of our best parameter, the
mean RGCL thickness in the inferior half of the macular region,
was essentially equal to the unadjusted AUC (0.85), indicating
an unbiased estimate.
Because of the limited number of cases, we did not analyze
early, moderate, and severe cases separately. However, we did
some exploratory analyses. Correctly identified cases had a
lower perimetric threshold sensitivity in the central part of the
visual field and a greater axial length compared to cases that
were not identified. The difference in axial length could be a
technical issue or a real influence of axial length on the
pathophysiology of glaucoma.47
In conclusion, in this population-based study OCT uncovers
abnormalities in the macular region in many cases with early
and moderate glaucoma detected with perimetry. Retinal
ganglion cell loss in the macular region is at least as common
as peripapillary RNFL abnormalities. The OCT-derived regional
thickness–based screening only leads to missing approximately
half of all glaucoma cases with manifest visual field loss in our
population.
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